Modelling Lymphatic Filariasis Transmission and Control: Modelling Frameworks, Lessons Learned and Future Directions

Advances in Parasitology

Volumn 87, Issue , 2015, Pages 249-291

  Stolk, Wilma A ^a   Stone, Chris ^b   de Vlas, Sake J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

Control; Elimination; Lymphatic filariasis; Mathematical modelling; Prediction; Review

Indexed keywords

ANTHELMINTIC AGENT;

ADAPTIVE IMMUNITY; ARTICLE; BASIC REPRODUCTION NUMBER; COMPUTER SIMULATION; DISEASE TRANSMISSION; DRUG BIOAVAILABILITY; HEALTH CARE PERSONNEL; HISTORY OF MEDICINE; HOUSEHOLD; HUMAN; INCUBATION TIME; INFECTION CONTROL; LYMPHATIC FILARIASIS; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; MOSQUITO BITE; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGRAM EFFECTIVENESS; RESISTANCE MANAGEMENT; VECTOR CONTROL; DISEASE ERADICATION; ELEPHANTIASIS, FILARIAL; THEORETICAL MODEL; TRANSMISSION; TRENDS;

DISEASE ERADICATION; ELEPHANTIASIS, FILARIAL; HUMANS; MODELS, THEORETICAL;

EID: 84924515137     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/bs.apar.2014.12.005     Document Type: Article

References (72)

1. Anderson R.M., May R.M. Helminth infections of humans: mathematical models, population dynamics, and control. Adv. Parasitol. 1985, 24:1-101.
2. Babu B.V., Mishra S. Mass drug administration under the programme to eliminate lymphatic filariasis in Orissa, India: a mixed-methods study to identify factors associated with compliance and non-compliance. Trans. R. Soc. Trop. Med. Hyg. 2008, 102(12):1207-1213.
3. Basáñez M.G., McCarthy J.S., French M.D., Yang G.J., Walker M., Gambhir M., Prichard R.K., Churcher T.S. A research agenda for helminth diseases of humans: modelling for control and elimination. PLoS Negl. Trop. Dis. 2012, 6:e1548.
4. Bhunu C.P., Mushayabasa S. Transmission dynamics of lymphatic filariasis: a mathematical approach. ISRN Biomath. 2012, 2012:1-9.
5. Bousema T., Drakeley C., Gesase S., Hashim R., Magesa S., Mosha F., Otieno S., Carneiro I., Cox J., Msuya E., Kleinschmidt I., Maxwell C., Greenwood B., Riley E., Sauerwein R., Chandramohan D., Gosling R. Identification ofhot spots of malaria transmission for targeted malaria control. J. Infect. Dis. 2010, 201:1764-1774.
6. Recommendations of the international task force for disease eradication. MMWR Morb. Mortal. Wkly. Rep. 1993, 42:1-38. Centers For Disease Control.
7. Chan M.S., Srividya A., Norman R.A., Pani S.P., Ramaiah K.D., Vanamail P., Michael E., Das P.K., Bundy D.A. Epifil: a dynamic model of infection and disease in lymphatic filariasis. Am. J. Trop. Med. Hyg. 1998, 59:606-614.
8. Chu B.K., Deming M., Biritwum N.K., Bougma W.R., Dorkenoo A.M., El-Setouhy M., Fischer P.U., Gass K., Gonzalez De Pena M., Mercado-Hernandez L., Kyelem D., Lammie P.J., Flueckiger R.M., Mwingira U.J., Noordin R., Offei Owusu I., Ottesen E.A., Pavluck A., Pilotte N., Rao R.U., Samarasekera D., Schmaedick M.A., Settinayake S., Simonsen P.E., Supali T., Taleo F., Torres M., Weil G.J., Won K.Y. Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation. PLoS Negl. Trop. Dis. 2013, 7:e2584.
9. Churcher, T.S., Kaplan, R.M., Ardelli, B.F., Schwenkenbecher, J.M., Basáñez, M.G., Lammie, P.J., 2010. Mass treatment of parasitic disease: implications for the spread of anthelmintic resistance. In: Weber, J.T. (Ed.), Antimicrobial Resistance - Beyond the Breakpoint. Issues in Infectious Diseases Series Vol. 6: 120-137. Basel (Switzerland), Karger.
10. Coelho F.C., Codeco C.T., Gomes M.G. A Bayesian framework for parameter estimation in dynamical models. PLoS One 2011, 6:e19616.
11. Courchamp F., Clutton-Brock T., Grenfell B. Inverse density dependence and the Allee effect. Trends Ecol. Evol. 1999, 14:405-410.
12. Diekmann O., Heesterbeek J.A., Roberts M.G. The construction of next-generation matrices for compartmental epidemic models. J. R. Soc. Interface 2010, 7:873-885.
13. Dietz K. The population dynamics of onchocerciasis. Population Dynamics of Infectious Diseases: Theory and Applications 1982, Chapman & Hall, London. R. Anderson (Ed.).
14. Dommar C.J., Lowe R., Robinson M., Rodo X. An agent-based model driven by tropical rainfall to understand the spatio-temporal heterogeneity of a chikungunya outbreak. Acta Trop. 2014, 129:61-73.
15. Duerr H.P., Dietz K., Eichner M. Determinants of the eradicability of filarial infections: a conceptual approach. Trends Parasitol. 2005, 21:88-96.
16. Dye C., Hasibeder G. Population dynamics of mosquito-borne disease: effects of flies which bite some people more frequently than others. Trans. R. Soc. Trop. Med. Hyg. 1986, 80:69-77.
17. Eberhard M.L., Lammie P.J., Dickinson C.M., Roberts J.M. Evidence of nonsusceptibility to diethylcarbamazine in Wuchereria bancrofti. J. Infect. Dis. 1991, 163:1157-1160.
18. Favier C., Schmit D., Muller-Graf C.D., Cazelles B., Degallier N., Mondet B., Dubois M.A. Influence of spatial heterogeneity on an emerging infectious disease: the case of dengue epidemics. Proc. Biol. Sci. 2005, 272:1171-1177.
19. Gambhir M., Bockarie M., Tisch D., Kazura J., Remais J., Spear R., Michael E. Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis. BMC Biol. 2010, 8:22.
20. Gambhir M., Michael E. Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis. PLoS One 2008, 3:e2874.
21. Gambhir M., Singh B.K., Michael E. The Allee effect and elimination of Neglected Tropical Diseases: a mathematical modelling study. Adv. Parasitol. 2015, 87:1-32.
22. Garnett G.P., Cousens S., Hallett T.B., Steketee R., Walker N. Mathematical models in the evaluation of health programmes. Lancet 2011, 378:515-525.
23. Geerts S., Gryseels B. Drug resistance in human helminths: current situation and lessons from livestock. Clin. Microbiol. Rev. 2000, 13:207-222.
24. Gubler D.J., Bhattacharya N.C. A quantitative approach to the study of Bancroftian filariasis. Am. J. Trop. Med. Hyg. 1974, 23:1027-1036.
25. Gweryina R.I., Luga T. Modelling the potential impact of chemotherapy and treatment on the dynamics of malaria-filariasis coinfection. Int. J. Mod. Math. Sci. 2014, 10:163-188.
26. Habbema J.D.F., De Vlas S.J., Plaisier A.P., Van Oortmarssen G.J. The microsimulation approach to epidemiologic modeling of helminthic infections, with special reference to schistosomiasis. Am. J. Trop. Med. Hyg. 1996, 55:165-169.
27. Hairston N.G., Jachowski L.A. Analysis of the Wuchereria bancrofti population in the people of American Samoa. Bull. World Health Organ. 1968, 38:29-59.
28. Hairston N.G., Meillon B.D. On the inefficiency of transmission of Wuchereria bancrofti from mosquito to human host. Bull. World Health Organ. 1968, 38:935-941.
29. Hayashi S. A mathematical analysis on the epidemiology of bancroftian and malayan filariasis in Japan. Jpn. J. Exp. Med. 1962, 32:13-43.
30. Heesterbeek J.A., Roberts M.G. Threshold quantities for helminth infections. J. Math. Biol. 1995, 33:415-434.
31. May R.M. Togetherness among schistosomes: its effects on the dynamics of the infection. Math. Biosci. 1977, 35:301-343.
32. McCarthy J. Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?. Am. J. Trop. Med. Hyg. 2005, 73:232-233.
33. Michael E. The population dynamics and epidemiology of lymphatic filariasis. Lymphatic Filariasis 2000, 41-84. Imperial College Press, London. T.B. Nutman (Ed.).
34. Michael E., Malecela-Lazaro M.N., Kabali C., Snow L.C., Kazura J.W. Mathematical models and lymphatic filariasis control: endpoints and optimal interventions. Trends Parasitol. 2006, 22:226-233.
35. Michael E., Malecela-Lazaro M.N., Kazura J.W. Epidemiological modelling for monitoring and evaluation of lymphatic filariasis control. Adv. Parasitol. 2007, 65:191-237. Elsevier Ltd.
36. Michael E., Malecela-Lazaro M.N., Maegga B.T., Fischer P., Kazura J.W. Mathematical models and lymphatic filariasis control: monitoring and evaluating interventions. Trends Parasitol. 2006, 22:529-535.
37. Michael E., Malecela-Lazaro M.N., Simonsen P.E., Pedersen E.M., Barker G., Kumar A., Kazura J.W. Mathematical modelling and the control of lymphatic filariasis. Lancet Infect. Dis. 2004, 4:223-234.
38. Michael E., Simonsen P.E., Malecela M., Jaoko W.G., Pedersen E.M., Mukoko D., Rwegoshora R.T., Meyrowitsch D.W. Transmission intensity and the immunoepidemiology of bancroftian filariasis in East Africa. Parasite Immunol. 2001, 23:373-388.
39. Norman R.A., Chan M.S., Srividya A., Pani S.P., Ramaiah K.D., Vanamail P., Michael E., Das P.K., Bundy D.A. EPIFIL: the development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis. Epidemiol. Infect. 2000, 124:529-541.
40. Ntd Modelling Consortium 2014, Available, (accessed 17.08.14.). http://www.ntdmodelling.org/.
41. Pichon G. Limitation and facilitation in the vectors and other aspects of the dynamics of filarial transmission: the need for vector control against Anopheles-transmitted filariasis. Ann. Trop. Med. Parasitol. 2002, 96:S143-S152.
42. Plaisier A.P., Stolk W.A., Van Oortmarssen G.J., Habbema J.D. Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection. Parasitol. Today 2000, 16:298-302.
43. Plaisier A.P., Subramanian S., Das P.K., Souza W., Lapa T., Furtado A.F., Van Der Ploeg C.P.B., Habbema J.D.F., Van Oortmarssen G.J. The LYMFASIM simulation program for modeling lymphatic filariasis and its control. Methods Inf. Med. 1998, 37:97-108.
44. Poole D., Raftery A.E. Inference for deterministic simulation models: the Bayesian melding approach. J. Am. Stat. Assoc. 2000, 95:12.
45. Prichard R.K. Is anthelmintic resistance a concern for heartworm control? what can we learn from the human filariasis control programs?. Vet. Parasitol. 2005, 133:243-253.
46. Prosper O., Ruktanonchai N., Martcheva M. Assessing the role of spatial heterogeneity and human movement in malaria dynamics and control. J. Theor. Biol. 2012, 303:1-14.
47. Rochet M.J. A simple deterministic model for bancroftian filariasis transmission dynamics. Trop. Med. Parasitol. 1990, 41:225-233.
48. Schwab A.E., Boakye D.A., Kyelem D., Prichard R.K. Detection of benzimidazole resistance-associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection by albendazole and ivermectin combination treatment. Am. J. Trop. Med. Hyg. 2005, 73:234-238.
49. Schwab A.E., Churcher T.S., Schwab A.J., Basáñez M.G., Prichard R.K. Population genetics of concurrent selection with albendazole and ivermectin or diethylcarbamazine on the possible spread of albendazole resistance in Wuchereria bancrofti. Parasitology 2006, 133:589-601.
50. Schwab A.E., Churcher T.S., Schwab A.J., Basáñez M.G., Prichard R.K. An analysis of the population genetics of potential multi-drug resistance in Wuchereria bancrofti due to combination chemotherapy. Parasitology 2007, 134:1025-1040.
51. Singh B.K., Bockarie M.J., Gambhir M., Siba P.M., Tisch D.J., Kazura J., Michael E. Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea. PLoS One 2013, 8:e67004.
52. Slater H.C., Gambhir M., Parham P.E., Michael E. Modelling co-infection with malaria and lymphatic filariasis. PLoS Comput. Biol. 2013, 9:e1003096.
53. Smith T., Maire N., Dietz K., Killeen G.F., Vounatsou P., Molineaux L., Tanner M. Relationship between the entomologic inoculation rate and the force of infection for Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 2006, 75:11-18.
54. Ssemanda E.N., Munoz B., Harding-Esch E.M., Edwards T., Mkocha H., Bailey R.L., Sillah A., Stare D., Mabey D.C., West S.K. Mass treatment with azithromycin for trachoma control: participation clusters in households. PLoS Negl. Trop. Dis. 2010, 4.
55. Stolk W.A. When can mass drug administration for lymphatic filariasis be stopped? Amodeling perspective. 56th Annual Meeting of theAmerican Society of Tropical Medicine and Hygiene. Philadelphia, Pennsylvania, USA 2007, [Conference presentation].
56. Stolk W.A., De Vlas S.J., Borsboom G.J., Habbema J.D. LYMFASIM, a simulation model for predicting the impact of lymphatic filariasis control: quantification for African villages. Parasitology 2008, 135:1583-1598.
57. Stolk W.A., De Vlas S.J., Habbema J.D. Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling. Filaria J. 2006, 5:5.
58. Stolk W.A., De Vlas S.J., Habbema J.D.F. Anti-Wolbachia treatment for lymphatic filariasis. Lancet 2005, 365:2067-2068.
59. Stolk W.A., Ramaiah K.D., Van Oortmarssen G.J., Das P.K., Habbema J.D.F., DeVlas S.J. Meta-analysis of age-prevalence patterns in lymphatic filariasis: no decline in microfilaraemia prevalence in older age groups as predicted by models with acquired immunity. Parasitology 2004, 129:605-612.
60. Stolk W.A., Subramanian S., Oortmarssen G.J., Das P.K., Habbema J.D.F. Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study. J. Infect. Dis. 2003, 188:1371-1381.
61. Stolk W.A., Ten Bosch Q.A., De Vlas S.J., Fischer P.U., Weil G.J., Goldman A.S. Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis. PLoS Negl. Trop. Dis. 2013, 7:e1984.
62. Stone C.M., Lindsay S.W., Chitnis N. How effective is integrated vector management against malaria and lymphatic filariasis where the diseases are transmitted by the same vector?. PLoS Negl. Trop. Dis. 2014, 8:e4493.
63. Subramanian S., Krishnamoorthy K., Ramaiah K.D., Habbema J.D.F., Das P.K., Plaisier A.P. The relationship between microfilarial load in the human host and uptake and development of Wuchereria bancrofti microfilariae by Culex quinquefasciatus: a study under natural conditions. Parasitology 1998, 116:243-255.
64. Subramanian S., Stolk W.A., Ramaiah K.D., Plaisier A.P., Krishnamoorthy K., Van Oortmarssen G.J., Amalraj D., Habbema J.D.F., Das P.K. The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India. Parasitology 2004, 128:467-482.
65. Turner H.C., Churcher T.S., Walker M., Osei-Atweneboana M.Y., Prichard R.K., Basáñez M.G. Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis. PLoS Negl. Trop. Dis. 2013, 7:e2169.
66. Informal Consultation on Epidemiological Modelling for Research and Control of Lymphatic Filariasis 1990, WHO, World Health Organization, Geneva.
67. Community directed treatment with ivermectin: report of a multi-country study. UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), in Collaboration with Onchocerciasis Control Programme in West Africa (OCP) and the African Programme for Onchocerciasis Control (APOC) 1996, WHO.
68. Elimination of Lymphatic Filariasis as a Public Health Problem-Resolution of the Executive Board of the WHO (WHA50.29) 1997, WHO, Fiftieth World Health Assembly, Geneva, Switzerland.
69. Global programme to eliminate lymphatic filariasis: monitoring and epidemiological assessment of mass drug administration. A Manual for National Elimination Programmes. Geneva, Switzerland 2011, WHO, World Health Organization.
70. Global programme to eliminate lymphatic filariasis: progress report for 2012. Wkly. Epidemiol. Rec. 2013, 88:389-399. WHO.
71. Sustaining the Drive to Overcome the Global Impact of Neglected Tropical Diseases. Second WHO Report on Neglected Tropical Diseases 2013, WHO, World Health Organization, Geneva, Switzerland.
72. Woolhouse M.E. A theoretical framework for the immunoepidemiology of helminth infection. Parasite Immunol. 1992, 14:563-578.